Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186150 | 0.76 | MEN1 (0.37) | — | |
| SCHEMBL8933622 | 0.70 | TSHR (0.35) | RIPK1TRPA1 | |
| SCHEMBL17559963 | 0.69 | — | — | |
| SCHEMBL17529803 | 0.68 | GAA (0.33) | RIPK1TRPA1 | |
| SCHEMBL4722999 | 0.66 | — | — | |
| SCHEMBL6226452 | 0.65 | TAAR1 (0.38) | — | |
| SCHEMBL18397 | 0.65 | MAPK1 (0.36) | — | |
| SCHEMBL29638967 | 0.64 | MAPK1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL22288246 | 0.64 | MAPK1 (0.35) | — | |
| Ethane SCHEMBL28152908 | 0.64 | MAPK1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10131607-B2 | Process for preparing unsymmetric OCO pincer ligands from the group of the M-terphenyl compounds | EVONIK DEGUSSA GMBH (DE) | 2018-11-20 | — | — | US | disclosed |
| US-20170050910-A1 | PROCESS FOR PREPARING UNSYMMETRIC OCO PINCER LIGANDS FROM THE GROUP OF THE M-TERPHENYL COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2017-02-23 | — | — | US | disclosed |
| EP-3133189-A1 | METHOD FOR THE PREPARATION OF ASYMMETRIC OCO PINCER LIGANDS FROM THE GROUP OF M TERPHENYL COMPOUNDS | Evonik Degussa GmbH (DE) | 2017-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10131607-B2 | Process for preparing unsymmetric OCO pincer ligands from the group of the M-terphenyl compounds | COMT, MSMO1, TYR | RIPK1 2510/4885TRPA1 165/4885CACNA1F 2615/4885 |
| US-20170050910-A1 | PROCESS FOR PREPARING UNSYMMETRIC OCO PINCER LIGANDS FROM THE GROUP OF THE M-TERPHENYL COMPOUNDS | COMT, MSMO1, TYR | RIPK1 2510/4885TRPA1 165/4885CACNA1F 2615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.